A curated selection of boutique venture capital firms and micro-VCs that specialize in early-stage funding for biotech, life sciences, and healthcare startups. These investors provide critical seed and pre-seed capital, along with specialized scientific and operational mentorship to help deep-tech founders navigate the long regulatory and development cycles inherent to the industry.
Get targeted exposure with custom position pinning and highlighted placement.
A pioneering venture capital firm that exclusively focuses on the life sciences sector, offering deep scientific expertise alongside capital. They specialize in founding new companies and supporting early-stage startups, leveraging a unique model that connects entrepreneurs with top-tier scientific and business talent.
Known for its 'venture building' approach, Flagship creates, funds, and grows transformative companies from the ground up in life sciences. They provide extensive resources, including access to their proprietary platforms and a vast network, making them ideal for founders seeking a partner deeply embedded in the scientific ecosystem.
An early-stage venture capital firm dedicated to investing in foundational technologies that address major human health challenges. They focus on seed and series A rounds in biotech, healthcare, and longevity, providing strategic support to help scientific innovations transition from laboratory to market.
A venture capital platform that bridges the gap between academic research and commercial viability in life sciences. They specialize in early-stage investments, offering founders access to a vast network of industry experts and operational support to accelerate the development of novel therapeutic and diagnostic solutions.
While a large VC firm, their healthcare group often acts as a micro-VC for early-stage biotech and digital health startups. They have a long history of backing transformative companies, providing not only capital but also extensive operational expertise and a global network to help founders scale effectively.
a16z has established a specialized bio + health fund that caters to early-stage startups in biotech and healthcare. They offer a unique 'builder' approach, providing scientific talent deployment and operational support alongside capital, which is crucial for navigating the complex regulatory pathways of life sciences.
Lux Capital focuses on building companies in the intersection of science and commerce, with a strong emphasis on biotech and sustainability. They take a long-term view, investing in early-stage ventures that leverage deep science to solve global challenges, often serving as an anchor investor for new scientific startups.
Ra Capital is an early-stage venture firm that invests in scientific discoveries and technological breakthroughs across various sectors, including biotech and healthcare. They are known for their rigorous due diligence and active support of founders, helping to translate complex scientific innovations into viable business models.
A prominent angel investor network that often acts as a micro-VC for early-stage tech and biotech startups. Founded by Ron Conway, SV Angel provides seed funding and strategic guidance, leveraging its vast network of industry leaders to help young companies gain traction and secure follow-on funding.
Comet Labs is a startup studio that invests in and builds technology companies, including those in the biotech and healthcare space. They offer deep operational support, technical talent, and capital, helping founders validate concepts and accelerate product development from ideation to market launch.
While a general startup accelerator, Y Combinator has a significant track record in biotech and life sciences, particularly with its dedicated biotech cohorts. They provide seed funding and intense mentorship, helping early-stage scientific founders refine their business models and connect with specialized life science investors.
This firm focuses on growth-stage investments but also engages in earlier rounds for promising biotech and digital health companies. They provide capital and operational expertise to help companies scale, with a focus on leveraging technology to improve healthcare outcomes and efficiency.
Foundry Group invests in early-stage technology companies, including those in the biotech and healthcare sectors. They look for companies that combine technology with deep science, providing strategic advice and access to their network of industry experts to help founders navigate the commercialization process.
Canaan Partners invests in early-stage technology companies, with a notable presence in the biotech and healthcare industries. They focus on identifying disruptive innovations and supporting founders through the critical early stages of development, offering both capital and strategic guidance to drive growth.
Atlas Venture is a venture capital firm that invests in early-stage life science and technology companies. They specialize in identifying transformative scientific discoveries and partnering with entrepreneurs to build companies, providing extensive resources and expertise to navigate the complex development landscape.
J&J Innovation acts as a strategic investor for early-stage biotech and healthcare startups, often functioning like a micro-VC in its seed investments. They provide capital, access to Johnson & Johnson's resources, and strategic partnerships to help innovative companies accelerate their path to market.
A private investment firm focused exclusively on the life sciences, Baker Brothers invests in early-stage companies with high growth potential. They leverage deep industry expertise and a global network to support founders, providing capital and strategic guidance to develop novel treatments and technologies.
Prelude Ventures invests in early-stage technology companies, with a focus on those that can impact global challenges, including in biotech. They provide capital and strategic support, helping founders build scalable businesses and navigate the early stages of commercialization for innovative scientific solutions.
Citi Ventures invests in early-stage technology and healthcare companies, often serving as a micro-VC for innovative startups. They provide capital and access to Citi's global network, helping life sciences companies secure financing and establish partnerships that drive growth and market entry.
While primarily known for large-scale investments, SoftBank's Vision Fund has backed early-stage biotech and healthcare startups with transformative potential. They provide significant capital and strategic resources, enabling founders to scale rapidly and compete in the global life sciences market.